Clinical trial · Observational
Study Evaluating the Impact of Short Message Service on Compliance With Surveillance of Patients With Germ-cell Tumors
Phase II, Open-label, Randomized, Non-comparative Study Evaluating the Impact of Short Message Service (SMS) on Compliance With Surveillance of Patients With Germ-cell Tumors. (TEXTIS Study)
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study will evaluate the impact of Short Message Service (SMS) on compliance with surveillance of patients with germ-cell tumors. Patients will be randomized in a 2:1 ratio to get 2 groups : (1) patients will receive reminder SMS before appointment detailing the date of consultation and exams to be performed before; (2) standard of care without SMS.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Compliance, Patient | — | UNRESOLVED | — |
| Follow-up | — | UNRESOLVED | — |
| Germ Cell Tumor | Germ Cell Tumor | ONTOLOGY_EXACT | 0.90 |
| Text Messaging | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| short message service | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Experimental: reminder SMS before appointment
- description
- SMS before appointment detailing the date of consultation and exams to be performed before
- interventionNames
- Other: short message service
- label
- Active comparator: standard of care
Primary outcomes (1)
- measure
- Rate of patients who report optimal compliance to surveillance
- timeFrame
- 1 year
- description
- Optimal compliance is defined according to the following 2 parameters: * The patient comes to all the appointments, on the expected day, AND * With all the biological and imaging exams previously scheduled by the physician.
Secondary outcomes (5)
- measure
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patient with germ cell tumor. * Patient with a mobile phone. * Patient on surveillance. Exclusion Criteria: * Testicular cancer without germ cell component. * Prior history of other malignancy except for: cutaneous cancers excluding melanoma, superficial bladder tumor, localized prostate cancer with undetectable PSA. * Cognitive condition that would preclude patient's understanding and completion of study procedures.
References
Publications (0)
Data not yet available